Clinical Trial Update: Clinical Trial Protocol: Randomized Placebo-Controlled Pilot Study of GcMAF (Soloways TM) in Patients With Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

A protocol for a randomized placebo-controlled Phase 3 pilot study of GcMAF in patients with metastatic breast cancer; recruitment has not yet begun.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• GcMAF (GcMAF)

Snippet

Sponsor: S.LAB (SOLOWAYS) | Conditions: Breast Cancer | Phase 3 | Status: NOT_YET_RECRUITING